Conteduca, Vincenza <br/><br/>
Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone.  [electronic resource] 

 -  The Prostate  Sep 2015 
 - 1329-38 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-0045 
<br/><br/><label>Standard No.: </label>10.1002/pros.23014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Androstenes--adverse effects<br/>Disease Progression<br/>Disease-Free Survival<br/>Enzyme Inhibitors--adverse effects<br/>Humans<br/>Male<br/>Metabolic Syndrome--complications<br/>Middle Aged<br/>Prostatic Neoplasms, Castration-Resistant--complications<br/>Retrospective Studies<br/>Risk Factors<br/>Steroid 17-alpha-Hydroxylase--antagonists & inhibitors<br/>Survival Rate<br/>Treatment Outcome